Fatty Liver and Heart Attack Risk Study
Part of Digestive system clinical trials.
This study is looking at how common a certain type of fatty liver disease is in people who have had a heart attack or unstable angina. If you've recently had a heart event and a coronary angiogram, the study will check your liver health to see if there is a link.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have had a recent heart attack or unstable angina (a heart-related chest pain) and have undergone a special heart X-ray test (coronary angiography)
- You do not have a history of alcohol or drug abuse
- You do not have hepatitis B or C
- You do not have any form of liver cancer
- You are not pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks how fatty liver disease (a condition where fat builds up in the liver) affects the heart. If you have this liver condition and are between 18 and 65, you may help doctors understand the link between liver health and heart function.
This study tests a way to find liver scarring (fibrosis) early in people who have risk factors like being overweight, having type 2 diabetes, or drinking alcohol heavily. Early detection may help prevent serious liver damage.
This study looks at people with fatty liver disease and common health issues like obesity, diabetes, high blood pressure, or abnormal cholesterol. It may help researchers understand how liver fat and heart/metabolism problems relate and how they affect health over time.
This study looks at whether the amount of fat in your liver, seen on an ultrasound, is linked to the severity of narrowing in your heart arteries. If you had a heart catheterization (angiography) and an abdominal ultrasound, your data may help researchers understand this connection.
This study checks how common fatty liver disease is in people with a genetic form of high cholesterol. It may help researchers understand the link between these two conditions.
This study looks at how the liver's immune environment changes in people with non-alcoholic fatty liver disease (NAFLD) that has progressed to significant scarring. Researchers will use a liver biopsy to understand the inflammation better, which may lead to new treatments.
Hear when a new Fatty Liver trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.